Medical News Today -
4 Oct 2013 11:00
People affected by leukemia and health care professionals who advocate for personalized medicine options could benefit from technology that is being developed with funding from a National Institutes of Health grant. Tymora Analytical Operations LLC, Purdue University and St. Jude Children's Research Hospital have been awarded a one-year, $300,000 Phase I STTR grant from the NIH. The groups will develop technology that could pinpoint the proteins inside cells affected by the disease so treatments...
Share this Article